IBDEI0Q5 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12901,0)
 ;;=605.^^87^826^43
 ;;^UTILITY(U,$J,358.3,12901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12901,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,12901,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,12901,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,12902,0)
 ;;=601.0^^87^826^45
 ;;^UTILITY(U,$J,358.3,12902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12902,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,12902,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,12902,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,12903,0)
 ;;=590.10^^87^826^47
 ;;^UTILITY(U,$J,358.3,12903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12903,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,12903,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,12903,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,12904,0)
 ;;=590.00^^87^826^48
 ;;^UTILITY(U,$J,358.3,12904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12904,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,12904,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,12904,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,12905,0)
 ;;=788.7^^87^826^54
 ;;^UTILITY(U,$J,358.3,12905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12905,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,12905,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,12905,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,12906,0)
 ;;=131.02^^87^826^57
 ;;^UTILITY(U,$J,358.3,12906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12906,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,12906,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,12906,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,12907,0)
 ;;=597.80^^87^826^56
 ;;^UTILITY(U,$J,358.3,12907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12907,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,12907,1,5,0)
 ;;=5^Urethritis, NOS
 ;;^UTILITY(U,$J,358.3,12907,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,12908,0)
 ;;=788.41^^87^826^58
 ;;^UTILITY(U,$J,358.3,12908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12908,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,12908,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,12908,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,12909,0)
 ;;=788.31^^87^826^61
 ;;^UTILITY(U,$J,358.3,12909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12909,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,12909,1,5,0)
 ;;=5^Urinary Incontinence, Urge
 ;;^UTILITY(U,$J,358.3,12909,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,12910,0)
 ;;=788.20^^87^826^62
 ;;^UTILITY(U,$J,358.3,12910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12910,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,12910,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,12910,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,12911,0)
 ;;=112.2^^87^826^64
 ;;^UTILITY(U,$J,358.3,12911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12911,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,12911,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,12911,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,12912,0)
 ;;=600.01^^87^826^5
 ;;^UTILITY(U,$J,358.3,12912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12912,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,12912,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,12912,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,12913,0)
 ;;=600.10^^87^826^39
 ;;^UTILITY(U,$J,358.3,12913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12913,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,12913,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,12913,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,12914,0)
 ;;=585.9^^87^826^8
 ;;^UTILITY(U,$J,358.3,12914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12914,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,12914,1,5,0)
 ;;=5^Chronic Renal Failure
